Search Results
Found 1 results
510(k) Data Aggregation
(74 days)
Renamel Flowable Composite is used for Class V restorations, small occlusal restorations, to seal margins, to repair pitted areas in restorations, as a pit and fissure sealant, to repair marginal defects, for bonding of fibrous splints and for direct resin veneers.
Renamel Flowable Composite is a system consisting of light-cured flowable composite restorative dental materials.
I am sorry, but the provided text does not contain the detailed information necessary to answer your request about acceptance criteria and a study proving device performance for the "Renamel Flowable Composite" device.
The document is a 510(k) clearance letter from the FDA, which confirms that the device is substantially equivalent to legally marketed predicate devices. It covers:
- Device Name: Renamel Flowable Composite
- Manufacturer: Cosmedent, Incorporated
- Regulatory Class: II
- Product Code: EBD
- Date of Clearance: February 10, 1998
- Indications for Use: Class V restorations, small occlusal restorations, to seal margins, to repair pitted areas in restorations, as a pit and fissure sealant, to repair marginal defects, for bonding of fibrous splints and for direct resin veneers.
- Device Description: A system consisting of light-cured flowable composite restorative dental materials. It also mentions a "confidential chemical analysis... in Appendix C," which is not provided.
However, the letter does not include:
- Specific acceptance criteria for performance.
- Details of any study (like sample sizes, data provenance, expert qualifications, ground truth establishment, MRMC studies, or standalone performance).
- Any performance metrics or results.
For a 510(k) submission, the primary aim is to demonstrate substantial equivalence to a predicate device, not necessarily to conduct de novo clinical trials with strict performance criteria and detailed study designs as might be found in a PMA (Premarket Approval) application or a more recent clinical study report. The FDA concluded that the device is substantially equivalent, implying that its performance characteristics are comparable to existing, legally marketed devices.
Therefore, I cannot populate the table or answer the specific questions about study design, sample sizes, expert involvement, or reported performance.
Ask a specific question about this device
Page 1 of 1